Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm A Smith

Showing results (41-50 of 188) with videos related to

Pageof 19
Sort By:
Pediatric Blood & Cancer|October 28, 2010
Evaluation of cytarabine against Ewing sarcoma xenografts by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, Min Kang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 21, 2010
Outcomes for children and adolescents with cancer: challenges for the twenty-first centuryMalcolm A Smith, Nita L Seibel, Sean F Altekruse, et al.
Pediatric Blood & Cancer|June 2, 2011
Combination testing (Stage 2) of the Anti-IGF-1 receptor antibody IMC-A12 with rapamycin by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, John M Maris, et al.
Pediatric Blood & Cancer|May 4, 2011
Combination testing of cediranib (AZD2171) against childhood cancer models by the pediatric preclinical testing programChristopher L Morton, John M Maris, Stephen T Keir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2017
Bioluminescence Imaging Enhances Analysis of Drug Responses in a Patient-Derived Xenograft Model of Pediatric ALLLuke Jones, Jennifer Richmond, Kathryn Evans, et al.
Pediatric Blood & Cancer|July 9, 2015
Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing programC Patrick Reynolds, Min H Kang, John M Maris, et al.
Journal of the National Cancer Institute|March 26, 2026
FDA approvals for pediatric cancer indications using children's oncology group associated trials dataMargaret E Macy, Elizabeth Fox, Brenda J Weigel, et al.
Pediatric Blood & Cancer|April 26, 2020
Evaluation of VTP-50469, a menin-MLL1 inhibitor, against Ewing sarcoma xenograft models by the pediatric preclinical testing consortiumRaushan T Kurmasheva, Abhik Bandyopadhyay, Edward Favours, et al.
Pediatric Blood & Cancer|January 25, 2020
Preclinical evaluation of the combination of AZD1775 and irinotecan against selected pediatric solid tumors: A Pediatric Preclinical Testing Consortium reportE Anders Kolb, Peter J Houghton, Raushan T Kurmasheva, et al.
Pediatric Blood & Cancer|February 19, 2010
Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the Pediatric Preclinical Testing ProgramPeter J Houghton, Christopher L Morton, Richard Gorlick, et al.
Pageof 19

Showing results (41-50 of 188) with videos related to

Sort By:
Pageof 19
Pediatric Blood & Cancer|October 28, 2010
Evaluation of cytarabine against Ewing sarcoma xenografts by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, Min Kang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 21, 2010
Outcomes for children and adolescents with cancer: challenges for the twenty-first centuryMalcolm A Smith, Nita L Seibel, Sean F Altekruse, et al.
Pediatric Blood & Cancer|June 2, 2011
Combination testing (Stage 2) of the Anti-IGF-1 receptor antibody IMC-A12 with rapamycin by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, John M Maris, et al.
Pediatric Blood & Cancer|May 4, 2011
Combination testing of cediranib (AZD2171) against childhood cancer models by the pediatric preclinical testing programChristopher L Morton, John M Maris, Stephen T Keir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2017
Bioluminescence Imaging Enhances Analysis of Drug Responses in a Patient-Derived Xenograft Model of Pediatric ALLLuke Jones, Jennifer Richmond, Kathryn Evans, et al.
Pediatric Blood & Cancer|July 9, 2015
Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing programC Patrick Reynolds, Min H Kang, John M Maris, et al.
Journal of the National Cancer Institute|March 26, 2026
FDA approvals for pediatric cancer indications using children's oncology group associated trials dataMargaret E Macy, Elizabeth Fox, Brenda J Weigel, et al.
Pediatric Blood & Cancer|April 26, 2020
Evaluation of VTP-50469, a menin-MLL1 inhibitor, against Ewing sarcoma xenograft models by the pediatric preclinical testing consortiumRaushan T Kurmasheva, Abhik Bandyopadhyay, Edward Favours, et al.
Pediatric Blood & Cancer|January 25, 2020
Preclinical evaluation of the combination of AZD1775 and irinotecan against selected pediatric solid tumors: A Pediatric Preclinical Testing Consortium reportE Anders Kolb, Peter J Houghton, Raushan T Kurmasheva, et al.
Pediatric Blood & Cancer|February 19, 2010
Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the Pediatric Preclinical Testing ProgramPeter J Houghton, Christopher L Morton, Richard Gorlick, et al.
Pageof 19